# An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft

> **NCT03187522** · NA · TERMINATED · sponsor: **Bolton Medical** · enrollment: 174 (actual)

## Conditions studied

- Aortic Aneurysm, Abdominal

## Interventions

- **DEVICE:** TREO Stent-Graft System

## Key facts

- **NCT ID:** NCT03187522
- **Lead sponsor:** Bolton Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-22
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 174 (ACTUAL)
- **Why stopped:** Post Market Study terminated early due to the launch and subsequent incorporation of the study into the Terumo Aortic Endovascular Registry (TiGER-001).
- **Last updated:** 2021-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03187522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03187522, "An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03187522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*